Company Profile

Gentra Systems Inc
Profile last edited on: 5/27/09      CAGE:       UEI:

Business Identifier: Tools for nucleic acid purification
Year Founded
1988
First Award
1992
Latest Award
2004
Program Status
Inactive (Acquired)
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

13355 10th Avenue North Suite 120
Minneapolis, MN 55441
   (763) 543-0678
   info@gentra.com
   www.gentra.com
Location: Single
Congr. District: 03
County: Hennepin

Public Profile

In May 2006, Gentra Systems, Inc. was acquired by QIAGEN N.V.. Gentra Systems, Inc. is a privately held biotechnology corporation focused solely on nucleic acid purification, Gentra develops and markets manual and automated nucleic acid purification products that address the need for high quality nucleic acid, ease of use and increased throughput for clinical and clinical research laboratories. Purifying nucleic acids used to be a slow, tedious process that mixed drudgery with toxicity: a frustrating means to an end. The coming molecular age needed new methods that were convenient, fast, reliable and non-toxic. Recognizing this need, Gentra Systems has focused solely on nucleic acid purification—paving the way for molecular technologies in clinical and clinical research applications. The Puregene® DNA Purification Kit was the first product developed and marketed by Gentra Systems. Introduced in 1991, it has set the standard for purifying archival quality DNA with exceptional yields. The Puregene kit is the only purification product supported by real time ongoing stability studies, which have now passed the 11-year mark. Gentra has developed and markets other DNA and RNA purification products including Generation®, Purescript® , Autopure ls® and its newest product, Versagene™ RNA, which is being launched in December 2003. Generation DNA Purification Kits provide rapid and reliable DNA purification for small samples and are available in a variety of formats – Capture Column, Capture Plate, Capture Disk and Capture Card. The Purescript kit provides a non-toxic method for purifying RNA in a scalable, simple-to-use format. The Autopure ls instrument has revolutionized the way many high-throughput laboratories are processing samples, by purifying Puregene-quality DNA from whole blood samples of up to 10 ml. Additional sample types include packed cells and buffy coats, cultured cells, cell lysates and buccal cells. Gentra Systems' newest product, Versagene RNA is a simple, yet effective, technology for isolating pure RNA from animal tissues, cultured cells or whole blood, and comes in a convenient easy-to-us

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
75-99
Revenue Range
7.5M-10M
VC funded?
Yes
Public/Private
Privately Held
Stock Info
----
IP Holdings
15-19

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2004 1 NIH $130,854
Project Title: DNA Purification Method for HPV Testing
2000 2 NIH $586,801
Project Title: Development of DNA Standards for Molecular HLA Typing
1993 2 USDA $256,675
Project Title: Developing a chicken MHC typing test using DNA amplification and oligonucleatide probes

Key People / Management

  Ruth M Shuman -- President

  Heather P Meehan

  Sandra Rosen-Bronson

Company News

There are no news available.